B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 27.46% 7.57% 75.27% -33.20% 213.26%
Total Depreciation and Amortization 0.07% 0.17% 0.05% 3.14% 6.71%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 114.95% -231.79% -33.14% 96.33% -94.35%
Change in Net Operating Assets -83.20% 206.13% 199.99% -212.97% 311.96%
Cash from Operations -2.74% 13.62% 100.89% -42.63% 23.31%
Capital Expenditure 66.02% -2,490.00% 94.97% 99.45% -56,295.31%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- 97.60%
Cash from Investing 66.02% -2,490.00% 94.97% 99.48% 58.72%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 50.43% 95.86% -98.57% 20,465.95% 226.89%
Repurchase of Common Stock -- -- 100.00% 54.97% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 89.08% -1,038.67% 31.13% -40.22% 91.25%
Cash from Financing 174.20% -616.34% -99.18% 21,310.38% 93.43%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 12.88% 2.08% -62.22% 936.75% 128.82%
Weiss Ratings